To explore the relationship between tumor purity and clinical characteristics, we ranked the tumor purity of the samples in the GSE16011, Rembrandt and TCGA-glioma datasets from low to high along with clinical characteristics, including WHO grade, EGFR, IDH1, and 1p/19q status, survival time, and age (Figure 1A). This evidence concerns the gene IDH1 and glioma.